Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in Hepatology Retrieve available abstracts of 248 articles: HTML format Text format

Single Articles

March 2010
1. PAWLOTSKY JM , Chevaliez S
   Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy?
   Hepatology. 2010;51:1072-1076.
   PubMed     Text format     Related articles   
   
   
   February 2010
2. LI JH , Qian Lao X, Tillmann HL, Rowell J, et al
   Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. HALFON P , Martinot-Peignoux M, Khiri H, Marcellin P, et al
   Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability.
   Hepatology. 2010.
   PubMed     Text format     Related articles   
   
   
   January 2010
4. WANG CC , Kao JH
   Metformin improves sustained virologic response in difficult-to-cure hepatitis C: More questions than answers.
   Hepatology. 2010;51:1082.
   PubMed     Text format     Related articles   
   
   
   
5. BRUNO S , Crosignani A, Facciotto C, Rossi S, et al
   Sustained virologic response prevents the development of esophageal varices in compensated, child-pugh class a hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. DIAGO M , Shiffman ML, Bronowicki JP, Zeuzem S, et al
   Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin.
   Hepatology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. TERRAULT N , Khalili M
   A glimpse of future hepatitis C virus treatment paradigms.
   Hepatology. 2010;51:707-710.
   PubMed     Text format     Related articles   
   
   
   
8. SHACKEL NA , Bowen DG, McCaughan GW
   Snipping away at hepatitis C.
   Hepatology. 2010;51:703-705.
   PubMed     Text format     Related articles   
   
   
   December 2009
9. KUNIHOLM MH , Kovacs A, Gao X, Xue X, et al
   Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
   Hepatology. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. AIT-GOUGHOULTE M , Banerjee A, Meyer K, Mazumdar B, et al
    Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. PETTA S , Camma C, Scazzone C, Tripodo C, et al
    Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
12. MARTINOT-PEIGNOUX M , Stern C, Maylin S, Ripault MP, et al
    Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. KRIEGER SE , Zeisel MB, Davis C, Thumann C, et al
    Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. KNAPP S , Warshow U, Hegazy D, Brackenbury L, et al
    Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BINI EJ , Perumalswami PV
    Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. FULLER MJ , Shoukry NH, Gushima T, Bowen DG, et al
    Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. FEUERSTADT P , Bunim AL, Garcia H, Karlitz JJ, et al
    Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. BELLECAVE P , Sarasin-Filipowicz M, Donze O, Kennel A, et al
    Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. MORIGUCHI H , Chung RT, Sato C
    An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.
    Hepatology. 2009;51:351-352.
    PubMed     Text format     Related articles   
    
    
    
20. CHEVALIEZ S , Fix J, Soulier A, Pawlotsky JM, et al
    Underestimation of hepatitis C virus genotype 4 RNA levels by the Cobas AmpliPrep/Cobas TaqMan assay.
    Hepatology. 2009;50:1681.
    PubMed     Text format     Related articles   
    
    
    
21. GERMER JJ , Bommersbach CE, Schmidt DM, Bendel JL, et al
    Quantification of genotype 4 hepatitis C virus RNA by the COBAS AmpliPrep/COBAS TaqMan hepatitis C virus test.
    Hepatology. 2009;50:1679-80.
    PubMed     Text format     Related articles   
    
    
    
22. PURNAK T , Ozaslan E
    Coffee intake and chronic hepatitis C.
    Hepatology. 2009;50:1673.
    PubMed     Text format     Related articles   
    
    
    October 2009
23. TUAILLON E , Mondain AM, Meroueh F, Ottomani L, et al
    Dried blood spot for hepatitis C virus serology and molecular testing.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HOU W , Tian Q, Zheng J, Bonkovsky HL, et al
    MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. WANG CC , Kao JH
    Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
26. DUONG FH , Christen V, Lin S, Heim MH, et al
    Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. MORIGUCHI H , Chung RT, Sato C
    New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. CARRION JA , Torres F, Crespo G, Miquel R, et al
    Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. GEROLDI D , Emanuele E
    Metformin in chronic hepatitis C virus hepatitis: Caution needed with sex-based subgroup analysis.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
30. YILMAZ Y , Yonal O, Imeryuz N
    Metformin, hepatitis C, and insulin resistance: Sufficient evidence?
    Hepatology. 2009;50:2054-2055.
    PubMed     Text format     Related articles   
    
    
    September 2009
31. LEISE M , Kim WR
    Hepatitis C nonresponders: Re-treat or retreat?
    Hepatology. 2009;50:1307-1309.
    PubMed     Text format     Related articles   
    
    
    
32. BRUNO S , Shiffman ML, Roberts SK, Gane EJ, et al
    Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ASLINIA F , Mindikoglu AL
    Radiofrequency ablation in patients with hepatocellular carcinoma.
    Hepatology. 2009;50:2053.
    PubMed     Text format     Related articles   
    
    
    
34. LEHMANN E , El-Tantawy WH, Ocker M, Bartenschlager R, et al
    The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. EVERHART JE , Wright EC, Goodman ZD, Dienstag JL, et al
    Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Hepatology. 2009;51:585-594.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. CIESEK S , Steinmann E, Wedemeyer H, Manns MP, et al
    Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. FAN X , Mao Q, Zhou D, Lu Y, et al
    High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
    Hepatology. 2009;50:1765-1772.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. BENGA WJ , Krieger SE, Dimitrova M, Zeisel MB, et al
    Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. NEUMANN-HAEFELIN C , Timm J, Schmidt J, Kersting N, et al
    Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Hepatology. 2009;51:54-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. MODI AA , Feld JJ, Park Y, Kleiner DE, et al
    Increased caffeine consumption is associated with reduced hepatic fibrosis.
    Hepatology. 2009;51:201-209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LO GH
    Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
    Hepatology. 2009;50:988.
    PubMed     Text format     Related articles   
    
    
    August 2009
42. CHANG S , Kodys K, Szabo G
    Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. MILNER KL , Chisholm D, George J
    The many faces of hepatitis c: Liver disease and type 2 diabetes.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
44. COREY KE , Kane E, Munroe C, Barlow LL, et al
    Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up.
    Hepatology. 2009;50:1030-1037.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PRADAT P , Trepo E, Potthoff A, Bakshi R, et al
    The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
46. VOLK ML , Tocco R, Saini S, Lok AS, et al
    Public health impact of antiviral therapy for hepatitis C in the United States.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. GONZALEZ O , Fontanes V, Raychaudhuri S, Loo R, et al
    The heat shock protein inhibitor Quercetin Attenuates hepatitis C virus production.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. NELSON DR
    Hepatitis C drug development at a crossroads.
    Hepatology. 2009;50:997-999.
    PubMed     Text format     Related articles   
    
    
    
49. GOODMAN ZD , Stoddard AM, Bonkovsky HL, Fontana RJ, et al
    Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. ITSUI Y , Sakamoto N, Kakinuma S, Nakagawa M, et al
    Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. ROMERO-GOMEZ M , Diago M, Andrade RJ, Calleja JL, et al
    Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. RUSTGI VK , Lee WM, Lawitz E, Gordon SC, et al
    Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. SUSSER S , Welsch C, Wang Y, Zettler M, et al
    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
54. SIMONIN Y , Disson O, Lerat H, Antoine E, et al
    Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. RASHID M , Mitchell JD, Cramp ME, Cross TJ, et al
    Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
56. FREEDMAN ND , Everhart JE, Lindsay KL, Ghany MG, et al
    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. NASCIMBENI M , Montange T, Law HK, Mallet V, et al
    Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
    Hepatology. 2009;51:353.
    PubMed     Text format     Related articles   
    
    
    
58. BUTT AA , Wang X, Moore CG
    Effect of hepatitis C virus and its treatment on survival.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. TSUTSUMI T , Matsuda M, Aizaki H, Moriya K, et al
    Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. ZHANG R , Wang L, Yu GR, Zhang X, et al
    MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
61. DEUFFIC-BURBAN S , Babany G, Lonjon-Domanec I, Deltenre P, et al
    Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. BERENGUER J , Alvarez-Pellicer J, Martin PM, Lopez-Aldeguer J, et al
    Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
63. BOONSTRA A , van der Laan LJ, Vanwolleghem T, Janssen HL, et al
    Experimental models for hepatitis C viral infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. MACIAS J , Berenguer J, Japon MA, Giron JA, et al
    Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. ROBERTS SK , Weltman MD, Crawford DH, McCaughan GW, et al
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ASRANI SK , Kim WR, Heimbach JK
    Survival benefit of liver transplantation: One size fits all or fits none?
    Hepatology. 2009;50:352-354.
    PubMed     Text format     Related articles   
    
    
    
67. HALFON P , Martinot-Peignoux M, Cacoub P
    The myth of occult hepatitis C infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
68. MARCOLONGO M , Young B, Dal Pero F, Fattovich G, et al
    A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. DALGARD O , Mangia A
    Management of patients with hepatitis C virus genotype 2 or 3: Comments on updated american association for the study of liver diseases practice guidelines.
    Hepatology. 2009;50:323.
    PubMed     Text format     Related articles   
    
    
    May 2009
70. KENNY-WALSH E
    Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification.
    Hepatology. 2009;50:349-351.
    PubMed     Text format     Related articles   
    
    
    
71. GIUGLIANO S , Oezkan F, Bedrejowski M, Kudla M, et al
    Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. RAUCH A , James I, Pfafferott K, Nolan D, et al
    Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
    Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns.
    Hepatology. 2009;49:2125.
    PubMed     Text format     Related articles   
    
    
    
74. PUOTI L , Bellis L, Guarisco R
    Liver biopsy in hepatitis C virus carriers with normal alanine aminotransferase levels.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
75. EMANUELE E
    Statins and hepatitis C virus: Friend or foe?
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
76. SWAN T , Curry J
    Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users.
    Hepatology. 2009;50:323-324.
    PubMed     Text format     Related articles   
    
    
    
77. BENHAMOU Y , Afdhal NH, Nelson DR, Shiffman ML, et al
    A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naive patients with chronic hepatitis C: ViSER1 results.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. KOTTILIL S , Yan MY, Reitano KN, Zhang X, et al
    Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
    Hepatology. 2009;50:34-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. HASSAN MM , Kaseb A, Li D, Patt YZ, et al
    Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
    Hepatology. 2009;49:1563-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BASSO M , Giannini EG, Torre F, Blanchi S, et al
    Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
    Hepatology. 2009;49:1442-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
81. EYRE NS , Baumert TF, Beard MR
    Closing the gap: The tight junction protein occludin and hepatitis C virus entry.
    Hepatology. 2009;49:1770-1772.
    PubMed     Text format     Related articles   
    
    
    
82. NATTERMANN J , Tacke F
    The structure behind diversity: Covariance networks in hepatitis C virus sequences are associated with treatment response.
    Hepatology. 2009;49:1767-1769.
    PubMed     Text format     Related articles   
    
    
    
83. PETERS MG
    Special populations with hepatitis B virus infection.
    Hepatology. 2009;49.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. ALY HH , Qi Y, Atsuzawa K, Usuda N, et al
    Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. YANO M , Ikeda M, Abe KI, Kawai Y, et al
    Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. VANNI E , Abate ML, Gentilcore E, Hickman I, et al
    Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. PUOTI C , Guarisco R, Bellis L, Spilabotti L, et al
    Diagnosis, management, and treatment of hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
88. CARRENO V , Bartolome J, Castillo I, Quiroga JA, et al
    Hepatitis C virus replication in patients with occult hepatitis C virus infection.
    Hepatology. 2009;49:2128-2129.
    PubMed     Text format     Related articles   
    
    
    
89. CASANOVAS T
    Treatment of chronic hepatitis C in hemodialysis patients.
    Hepatology. 2009;49:2126.
    PubMed     Text format     Related articles   
    
    
    
90. PURNAK T
    The role of effectively treated chronic hepatitis C infection in the development of type 2 diabetes mellitus.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
91. LUCEY MR , Schaubel DE, Guidinger MK, Tome S, et al
    Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. LIU Z , Robida JM, Chinnaswamy S, Yi G, et al
    Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. BERG T , Weich V, Teuber G, Klinker H, et al
    Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. MAILLIARD ME , Capadano ME, Hrnicek MJ, Gilroy RK, et al
    Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. CHEVALIEZ S , Bouvier-Alias M, Castera L, Pawlotsky JM, et al
    The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples.
    Hepatology. 2009;49:1397-8.
    PubMed     Text format     Related articles   
    
    
    
96. GHANY MG , Strader DB, Thomas DL, Seeff LB, et al
    Diagnosis, management, and treatment of hepatitis C: an update.
    Hepatology. 2009;49:1335-74.
    PubMed     Text format     Related articles   
    
    
    
97. KAPOOR S
    Emerging new chemokine CXCR3 antagonists and their potential clinical and therapeutic applications.
    Hepatology. 2009;49:1400-1.
    PubMed     Text format     Related articles   
    
    
    
98. UTO H , Stuver SO, Hayashi K, Kumagai K, et al
    Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
99. DOGRU T , Ercin CN, Tapan S, Polat Z, et al
    Insulin resistance in prediction of esophageal varices.
    Hepatology. 2009.
    PubMed     Text format     Related articles   
    
    
    
100. HOFMANN WP , Zeuzem S
     Advanced chronic hepatitis C: How to handle if you cannot halt?
     Hepatology. 2009;49:1385-1387.
     PubMed     Text format     Related articles   
     
     
     
101. BELLECAVE P , Gouttenoire J, Gajer M, Brass V, et al
     Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
102. DELANG L , Paeshuyse J, Vliegen I, Leyssen P, et al
     Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. LABONTE P , Begley S, Guevin C, Asselin MC, et al
     PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. WANG XX , Song ZZ
     Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
     Hepatology. 2009;49:1775.
     PubMed     Text format     Related articles   
     
     
     
105. YANG JC , Teng CF, Wu HC, Tsai HW, et al
     Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis.
     Hepatology. 2009;49:1962-1971.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. FLISIAK R , Feinman SV, Jablkowski M, Horban A, et al
     The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. BACON BR , Shiffman ML, Mendes F, Ghalib R, et al
     Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LOK AS , Everhart JE, Chung RT, Kim HY, et al
     Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. SEBASTIANI G , Halfon P, Castera L, Pol S, et al
     SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. HUANG CF , Dai CY, Huang JF, Chuang WL, et al
     A crossing in therapy for hepatitis C virus genotype 2 or 3: Increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration.
     Hepatology. 2009;49:1395-1396.
     PubMed     Text format     Related articles   
     
     
     
111. MASUZAKI R , Tateishi R, Yoshida H, Goto E, et al
     Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. WELZEL TM , Morgan TR, Bonkovsky HL, Naishadham D, et al
     Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. LEMMERS A , Moreno C, Gustot T, Marechal R, et al
     The interleukin-17 pathway is involved in human alcoholic liver disease.
     Hepatology. 2009;49:646-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
114. AGHEMO A , Grazia Rumi M, Maria Prati G, Colombo M, et al
     The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: Should we utilize more?
     Hepatology. 2009;49.
     PubMed     Text format     Related articles   
     
     
     
115. HASSAN M , Selimovic D, Ghozlan H, Abdel-Kader O, et al
     Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. PARENT R , Qu X, Petit MA, Beretta L, et al
     The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. BRENNDORFER ED , Karthe J, Frelin L, Cebula P, et al
     Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase.
     Hepatology. 2009;49:1810-1820.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. YOUNOSSI ZM , Baranova A, Afendy A, Collantes R, et al
     Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. MYERS RP , Shaheen AA
     Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity.
     Hepatology. 2009;49:1399-1400.
     PubMed     Text format     Related articles   
     
     
     
120. GRAZIADEI IW , Vogel W
     Treatment of patients infected with chronic hepatitis C genotype 2 and 3: More data, more questions?
     Hepatology. 2009;49:345-347.
     PubMed     Text format     Related articles   
     
     
     
121. MORICE Y , Ratinier M, Miladi A, Chevaliez S, et al
     Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.
     Hepatology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
122. KAPOOR S
     Beyond hepatitis C: The anti-inflammatory role of heme oxygenase-1 in systemic infections.
     Hepatology. 2008;49:1052.
     PubMed     Text format     Related articles   
     
     
     
123. MOREAU I , Kenny-Walsh E, Crosbie O, Fanning LJ, et al
     Histological changes in hepatitis C virus antibody-positive, hepatitis C virus RNA-negative subjects suggest persistent virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
124. MACPARLAND SA , Pham TN, Guy CS, Michalak TI, et al
     Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. SAGNELLI E , Coppola N, Pisaturo M, Masiello A, et al
     HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. FIEL MI , Schiano T
     Jaundice developing in a patient with hepatitis C 4 months after liver transplantation.
     Hepatology. 2008;49:695-696.
     PubMed     Text format     Related articles   
     
     
     
127. GAUDIERI S , Rauch A, Pfafferott K, Barnes E, et al
     Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. HEYDTMANN M , Adams DH
     Chemokines in the immunopathogenesis of hepatitis C infection.
     Hepatology. 2008;49:676-688.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. MOLLEKEN C , Sitek B, Henkel C, Poschmann G, et al
     Detection of novel biomarkers of liver cirrhosis by proteomic analysis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
130. TILLMANN H , Patel K, McHutchison J
     Hepatitis B virus viral load and treatment decision.
     Hepatology. 2008;49:699.
     PubMed     Text format     Related articles   
     
     
     
131. WIESNER RH
     Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
     Hepatology. 2008;48:1734-1736.
     PubMed     Text format     Related articles   
     
     
     
132. LUCIDARME D , Foucher J, Le Bail B, Vergniol J, et al
     Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. URA S , Honda M, Yamashita T, Ueda T, et al
     Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. CALVARUSO V , Burroughs AK, Standish R, Manousou P, et al
     Computer-assisted image analysis of liver collagen: Relationship to ishak scoring and hepatic venous pressure gradient.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. GEORGE SL , Bacon BR, Brunt EM, Mihindukulasuriya KL, et al
     Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. YE L , Wang X, Wang S, Wang Y, et al
     CD56(+) T cells inhibit hepatitis C virus replication in human hepatocytes.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. KNETEMAN NM , Howe AY, Gao T, Lewis J, et al
     HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
138. TACKE F , Weiskirchen R, Trautwein C
     Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis.
     Hepatology. 2008;48:1724-1725.
     PubMed     Text format     Related articles   
     
     
     
139. WELKER MW , Zeuzem S
     Occult hepatitis C: How convincing are the current data?
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
140. WASMUTH HE , Tag CG, Van de Leur E, Hellerbrand C, et al
     The marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
     Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. 
     Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia.
     Hepatology. 2008;49:658-664.
     PubMed     Text format     Related articles   
     
     
     
143. HAGIST S , Sultmann H, Millonig G, Hebling U, et al
     In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology.
     Hepatology. 2008;49:378-386.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. AITKEN CK , Lewis J, Tracy SL, Spelman T, et al
     High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. MANGIA A , Minerva N, Bacca D, Cozzolongo R, et al
     Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. GOTTWEIN JM , Scheel TK, Jensen TB, Lademann JB, et al
     Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. BELLECAVE P , Moradpour D
     A fresh look at interferon-alpha signaling and treatment outcomes in chronic hepatitis C.
     Hepatology. 2008;48:1330-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. DORE GJ , Haber PS
     Tell me it ain't so: patient-to-patient transmission of hepatitis C in an endoscopy clinic.
     Hepatology. 2008;48:1333-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. NGUYEN GC , Sam J, Thuluvath PJ
     Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis.
     Hepatology. 2008;48:1336-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. CHEN TH , Chiu SY
     Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
     Hepatology. 2008;48:1348-9.
     PubMed     Text format     Related articles   
     
     
     
151. POCKROS P , Nelson D, Godofsky E, Rodriguez-Torres M, et al
     High relapse rate seen at week 72 for patients treated with R1626 combination therapy.
     Hepatology. 2008;48:1349-50.
     PubMed     Text format     Related articles   
     
     
     September 2008
152. CAMMA C , Petta S, Di Marco V, Bronte F, et al
     Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. BENEDICTO I , Molina-Jimenez F, Barreiro O, Maldonado-Rodriguez A, et al
     Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. ZHONG YD , Yang YF
     Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
     Hepatology. 2008.
     PubMed     Text format     Related articles   
     
     
     
155. YOON JC , Shiina M, Ahlenstiel G, Rehermann B, et al
     Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. LAGUNO M , Cifuentes C, Murillas J, Veloso S, et al
     Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. EL-SERAG HB , Engels EA, Landgren O, Chiao E, et al
     Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. ASSELAH T , Bieche I, Laurendeau I, Martinot-Peignoux M, et al
     Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.
     Hepatology. 2008;48:953-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
159. LONARDO A , Loria P
     The hepatitis C virus-associated dysmetabolic syndrome.
     Hepatology. 2008;48:1018-1019.
     PubMed     Text format     Related articles   
     
     
     
160. YU ML , Dai CY, Huang JF, Chuang WL, et al
     Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: The role of weight-based ribavirin exposure.
     Hepatology. 2008;48:1019-1020.
     PubMed     Text format     Related articles   
     
     
     
161. FUJITA T
     Retinol-binding protein 4 as a circulating marker of hepatic steatosis.
     Hepatology. 2008;48:1725.
     PubMed     Text format     Related articles   
     
     
     
162. SIR D , Chen WL, Choi J, Wakita T, et al
     Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. MCGOVERN BH , Abu Dayyeh BK, Chung RT
     Avoiding therapeutic pitfalls: The rational use of specifically targeted agents against hepatitis C infection.
     Hepatology. 2008;48:1700-1712.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. DALGARD O , Mangia A
     Short treatment to patients with genotype 2 or 3.
     Hepatology. 2008;48:694.
     PubMed     Text format     Related articles   
     
     
     
165. ARGO CK , Loria P, Caldwell SH, Lonardo A, et al
     Statins in liver disease: a molehill, an iceberg, or neither?
     Hepatology. 2008;48:662-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
166. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
     Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
     Hepatology. 2008;48:692-693.
     PubMed     Text format     Related articles   
     
     
     
167. IORIO R , Cirillo F, Terlizzi V, Giannattasio A, et al
     Children with chronic hepatitis C: What future?
     Hepatology. 2008;48:691-692.
     PubMed     Text format     Related articles   
     
     
     
168. LAGGING M , Langeland N, Pedersen C, Farkkila M, et al
     Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
     Hepatology. 2008;48:695.
     PubMed     Text format     Related articles   
     
     
     
169. GRIFFIN S , Stgelais C, Owsianka AM, Patel AH, et al
     Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. BERENGUER M
     Treatment of chronic hepatitis C in hemodialysis patients.
     Hepatology. 2008;48:1690-1699.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. MARUKIAN S , Jones CT, Andrus L, Evans MJ, et al
     Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. MEULEMAN P , Hesselgesser J, Paulson M, Vanwolleghem T, et al
     Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
     Hepatology. 2008;48:1761-1768.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. KUNTZEN T , Timm J, Berical A, Lennon N, et al
     Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients.
     Hepatology. 2008;48:1769-1778.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. SHIRAKAWA H , Matsumoto A, Joshita S, Komatsu M, et al
     Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. TAN JA , Joseph TA, Saab S
     Treating hepatitis C in the prison population is cost-saving.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. ZHU Z , Wilson AT, Mathahs MM, Wen F, et al
     Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
     Hepatology. 2008;48:1430-1439.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. MORISHIMA C , Morgan TR, Everhart JE, Wright EC, et al
     Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. YANG W , Hood BL, Chadwick SL, Liu S, et al
     Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. ZEREMSKI M , Petrovic LM, Chiriboga L, Brown QB, et al
     Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. LA VECCHIA C
     Cancer and liver cancer prevention: is it a fact or just a potential?
     Hepatology. 2008;48:7-9.
     PubMed     Text format     Related articles   
     
     
     
181. BLUHER M , Tonjes A, Stumvoll M
     Does retinol-binding protein 4 cause or reflect fatty liver disease?
     Hepatology. 2008;48:4-6.
     PubMed     Text format     Related articles   
     
     
     
182. KAWUT SM , Krowka MJ, Trotter JF, Roberts KE, et al
     Clinical risk factors for portopulmonary hypertension.
     Hepatology. 2008;48:196-203.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. SEKI E , Brenner DA
     Toll-like receptors and adaptor molecules in liver disease: update.
     Hepatology. 2008;48:322-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
184. POCKROS PJ , Nelson D, Godofsky E, Rodriguez-Torres M, et al
     R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. PIODI A , Chouteau P, Lerat H, Hezode C, et al
     Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
     Hepatology. 2008;48:16-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. MIURA K , Taura K, Kodama Y, Schnabl B, et al
     Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. VON WAGNER M , Hofmann WP, Teuber G, Berg T, et al
     Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. HOARE M , Gelson WT, Rushbrook SM, Curran MD, et al
     Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. FRIED MW , Jensen DM, Rodriguez-Torres M, Nyberg LM, et al
     Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon alpha-2a and ribavirin.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. HARRIS RA , Sugimoto K, Kaplan DE, Ikeda F, et al
     Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. PHAM TN , Michalak TI
     Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
192. SCHIAVON LL , Carvalho-Filho RJ, Narciso-Schiavon JL, Barbosa DV, et al
     Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
193. SANZ-CAMENO P , Martin-Vilchez S, Rodriguez-Munoz Y, Moreno-Otero R, et al
     Implicaton of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     May 2008
194. BALAN V , Ruppert K, Demetris AJ, Ledneva T, et al
     Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database.
     Hepatology. 2008;48:878-888.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. POLYAK SJ , Morishima C, Hawke R
     Antiviral effects of silymarin against hepatitis C: The jury is still out.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
196. MORCOS PN , Brennan B, Smith PF
     A grapefruit a day for patients infected with hepatitis C?
     Hepatology. 2008;47:2141-2142.
     PubMed     Text format     Related articles   
     
     
     
197. TORRES DM , Harrison SA
     Insulin resistance in chronic hepatitis C, genotypes 1 and 4: The unfortunate reality.
     Hepatology. 2008;47:2137-2139.
     PubMed     Text format     Related articles   
     
     
     
198. YU ML , Dai CY, Huang JF, Chiu CF, et al
     Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial.
     Hepatology. 2008;47:1884-1893.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. KATO T , Choi Y, Elmowalid G, Sapp RK, et al
     Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. MUHANNA N , Doron S, Wald O, Horani A, et al
     Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
     Hepatology. 2008;48:963-977.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. ZEUZEM S , Yoshida EM, Benhamou Y, Pianko S, et al
     Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C.
     Hepatology. 2008;48:407-417.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. CUA IH , Hui JM, Kench JG, George J, et al
     Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. MORENO-OTERO R , Trapero M, Moreno-Monteagudo JA
     Chronic hepatitis C genotype 2 or 3 short treatment.
     Hepatology. 2008;47:1796.
     PubMed     Text format     Related articles   
     
     
     April 2008
204. PALMER C , Hampartzoumian T, Lloyd A, Zekry A, et al
     A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.
     Hepatology. 2008;48:374-384.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. THEIN HH , Yi Q, Dore GJ, Krahn MD, et al
     Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. NEVEU B , Debeaupuis E, Echasserieau K, le Moullac-Vaidye B, et al
     Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. KARTHE J , Tessmann K, Li J, Machida R, et al
     Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin.
     Hepatology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. SCHAFER DF
     Chronic genotype 4 hepatitis C.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
209. JACOBSON IM , Brown RS Jr
     WIN-R revisited: Response to editorial.
     Hepatology. 2008;47:1427.
     PubMed     Text format     Related articles   
     
     
     March 2008
210. ZEKRY A , Freiman J
     Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?
     Hepatology. 2008;47:1418-1421.
     PubMed     Text format     Related articles   
     
     
     
211. EBIHARA T , Shingai M, Matsumoto M, Wakita T, et al
     Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. EL-SHAMY A , Nagano-Fujii M, Sasase N, Imoto S, et al
     Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. ROBERTS SK , Cooksley G, Dore GJ, Robson R, et al
     Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. PETTA S , Camma C, Di Marco V, Alessi N, et al
     Retinol-binding protein 4: A new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. SWAN T , Chung RT
     Development of novel agents for the treatment of hepatitis C virus.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
216. JONSSON JR , Barrie HD, O'Rourke P, Clouston AD, et al
     Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
     Hepatology. 2008;48:80-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. LEE SH , Song R, Lee MN, Kim CS, et al
     A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection.
     Hepatology. 2008;47:854-66.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
218. ZEISEL MB , Cosset FL, Baumert TF
     Host neutralizing responses and pathogenesis of hepatitis C virus infection.
     Hepatology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
219. BORTOLAMI M , Cardin R, Kotsafti A, Farinati F, et al
     TGF-beta and hepatocellular carcinoma.
     Hepatology. 2008;47:1095.
     PubMed     Text format     Related articles   
     
     
     
220. HIASA Y , Kuzuhara H, Tokumoto Y, Konishi I, et al
     Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. BEARD MR , Helbig KJ
     Control of HCV replication: When size does not matter.
     Hepatology. 2008;47:1092-1094.
     PubMed     Text format     Related articles   
     
     
     
222. SHEIKH MY , Choi J, Qadri I, Friedman JE, et al
     Hepatitis C virus infection: Molecular pathways to metabolic syndrome.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. FERENCI P , Brunner H, Laferl H, Scherzer TM, et al
     A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. LAGGING M , Langeland N, Pedersen C, Farkkila M, et al
     Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. VELDT BJ , Chen W, Heathcote EJ, Wedemeyer H, et al
     Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
     Hepatology. 2008;47:1856-1862.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
226. VANWOLLEGHEM T , Bukh J, Meuleman P, Desombere I, et al
     Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. NEUMANN-HAEFELIN C , Timm J, Spangenberg HC, Wischniowski N, et al
     Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. KAMAL SM , Nasser IA
     Hepatitis C genotype 4: What we know and what we don't yet know.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. HSU CS , Kao JH
     Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?
     Hepatology. 2008;47:760-761.
     PubMed     Text format     Related articles   
     
     
     
230. ADLER M , Gulbis B, Moreno C, Evrard S, et al
     The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
     Hepatology. 2008;47:762-763.
     PubMed     Text format     Related articles   
     
     
     
231. VALLET-PICHARD A , Mallet V, Pol S
     Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C.
     Hepatology. 2008;47:763.
     PubMed     Text format     Related articles   
     
     
     
232. COLSON P , Brouk N, Lembo F, Castellani P, et al
     Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naive chronically infected patient.
     Hepatology. 2008;47:766-767.
     PubMed     Text format     Related articles   
     
     
     
233. LAU DT , Fish PM, Sinha M, Owen DM, et al
     Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. TRUJILLO-MURILLO K , Rincon-Sanchez AR, Martinez-Rodriguez H, Bosques-Padilla F, et al
     Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. LOUSTAUD-RATTI V , Alain S, Rousseau A, Hubert IF, et al
     Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
     Hepatology. 2008;47:1453-1461.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. NORTHFIELD JW , Kasprowicz V, Lucas M, Kersting N, et al
     CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
     Hepatology. 2008;47:396-406.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. FLISIAK R , Horban A, Gallay P, Bobardt M, et al
     The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
     Hepatology. 2008;47:817-826.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. NAHMIAS Y , Goldwasser J, Casali M, van Poll D, et al
     Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
     Hepatology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. STERLING RK , Contos MJ, Smith PG, Stravitz RT, et al
     Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
     Hepatology. 2008;47:1118-1127.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. KUROSAKI M , Izumi N
     External validation of FIB-4: diagnostic accuracy is limited in elderly populations.
     Hepatology. 2008;47:352.
     PubMed     Text format     Related articles   
     
     
     December 2007
241. BERNARDIN F , Tobler L, Walsh I, Williams JD, et al
     Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.
     Hepatology. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. DHAREL N , Kato N, Muroyama R, Taniguchi H, et al
     Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. VARNHOLT H , Drebber U, Schulze F, Wedemeyer I, et al
     MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
     Hepatology. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. WISE M , Bialek S, Finelli L, Bell BP, et al
     Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
     Hepatology. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. YU ML , Dai CY, Huang JF, Hsieh MY, et al
     Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
     Hepatology. 2007;47:1792-1793.
     PubMed     Text format     Related articles   
     
     
     
246. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
     Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2.
     Hepatology. 2007;.
     PubMed     Text format     Related articles   
     
     
     
247. HOEFS JC , Morgan TR
     Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
     Hepatology. 2007;46:1671-4.
     PubMed     Text format     Related articles   
     
     
     
248. VAN DER POORTEN D , Kenny DT, Butler T, George J, et al
     Liver disease in adolescents: A cohort study of high-risk individuals.
     Hepatology. 2007;46:1750-8.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: